A Study of the Effect of SYN-010 on Subjects With IBS-C
Completed · Phase 2 · Has a placebo group
Conditions studied: Irritable Bowel Syndrome With Constipation (IBS-C)
In brief
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of the Effect of Two Dosage Strengths of SYN-010 Compared with Placebo on Breath Methane Production in Breath Methane-Positive Subjects with Irritable Bowel Syndrome with Constipation (IBS-C)
Key facts
- Study ID
- NCT02495623
- Run by
- Theriva Biologics, Inc.
- People needed
- 63
- Starts
- 2015-06-01
- Expected to finish
- 2015-11-01
- Last updated by the study team
- 2018-11-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects must have IBS-C and have a positive breath CH4 test result (> 10 ppm) at Screening.
- Subject must meet the modified Rome III criteria for IBS-C.
- Subject must have an average abdominal pain intensity score of ≥ 3 (scale 0-10) reported at Screening and Baseline.
- Subject must have an average of fewer than 3 complete spontaneous bowel movement (CSBMs) per week.
- Subject must agree to refrain from making any lifestyle changes that may affect IBS-C symptoms from the time of Screening to the end of the study.
You may not qualify if…
- Subject has taken IBS treatments (prescription or over-the-counter), proton pump inhibitors, laxatives, antibiotics.
- Subject currently has any structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility, or any unexplained and clinically significant symptoms such as lower GI bleeding, rectal bleeding, heme-positive stool, iron-deficiency anemia, weight loss, or systemic signs of infection.
- Subject has been diagnosed with or has a family history of familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, or any other form of familial colorectal cancer.
- Subject reports loose (mushy) or watery stools (Bristol Stool Form Scale [BSFS] score of 6 or 7).
Where it is running
- Study site — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.